02.17.2016
New program will monitor quality and safety of radiation therapy at VHA centers nationwide.
By Julia Evangelou Strait
Washington University School of Medicine in St. Louis has been selected to lead national efforts to improve and standardize radiation therapy for veterans with cancer.
The goal is to ensure that veterans across the U.S. receive the same high-quality radiation therapy at any of the 40 Veterans Health Administration (VHA) radiation oncology centers nationwide. Working with the American Society for Radiation Oncology, Washington University radiation oncologists — members of Siteman Cancer Center — are developing a system to provide continuous feedback on the progress, quality and safety of each veteran’s cancer therapy. The VHA, an arm of the U.S. Department of Veterans Affairs, is the country’s largest integrated health-care system, serving more than 8 million veterans each year.
“We are pleased to be taking a lead role in managing this program,” said Jeff M. Michalski, MD, the Carlos Perez Distinguished Professor of Radiation Oncology and a member of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. “We have significant experience working with the National Cancer Institute to provide platforms for assessing quality and standards of care for patients, and we are excited to work with the American Society for Radiation Oncology to bring that experience to bear on behalf of our nation’s veterans.”
Along with surgery and chemotherapy, radiotherapy is a major treatment method for a variety of cancer types. About 60 percent of all cancer patients receive some form of radiation therapy.
The new program is called the Radiation Oncology Practice Assessment Program. In the first year, radiation oncologists will set up the infrastructure required to evaluate quality of care for veterans undergoing treatment for lung and prostate cancers. To provide detailed evaluations for individual patients, the program will rely on new information technologies that will draw on the VHA’s electronic medical record system as well as treatment management systems that control and track how radiation is delivered to each patient. Much of the software that will enable this new reporting system was developed by Radialogica, a St. Louis-based health-care information technology company co-founded by Washington University faculty.
The new program will provide VHA radiation oncologists with detailed analyses of their patients’ treatments, compared with national standards. The feedback also will include traditional measures of cancer therapy outcomes, including patient survival and tumor recurrence. The aim is to provide oncologists with complete and consistent snapshots of each patient’s therapy and response to the treatment on a continuous basis.
Once the new program is fully in place, VHA radiation oncologists will receive continuously updated electronic reviews of each patient’s cancer evaluation, treatment and outcome.
The new automated system goes well beyond the current periodic review process, according to the developers. Instead of analyzing physician performance, the new system focuses on the patient, allowing doctors to see how changes in clinical practice, radiation planning, delivery technology and radiation dose prescription impact the success of a patient’s therapy. “We are pleased to be working with leading organizations on this innovative program, the first of its kind nationwide,” said Maureen McCarthy, MD, Veterans Affairs acting assistant deputy undersecretary for health and patient-care services. “Our veterans deserve nothing less.”
Washington University School of Medicine’s 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.
Siteman Cancer Center, ranked among the top cancer treatment centers by U.S. News & World Report, also is one of only a few cancer centers in the U.S. to receive the highest rating of the National Cancer Institute (NCI). Comprising the cancer research, prevention and treatment programs of Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Siteman is Missouri’s only NCI-designated Comprehensive Cancer Center and the state’s only member of the National Comprehensive Cancer Network.
Reprinted with permission from Washington University in St. Louis
PR 2016_01
Version 1.0
17 February 2016
12.08.2015
Radialogica, a healthcare analytics company focused on radiation therapy for cancer patients, announced the appointment of Dr. Cliff Robinson as Chief Medical Officer and Chair of the company’s Medical Advisory Board. In this role Dr. Robinson will collaborate on the design and implementation of software tools and analytics services to help healthcare clinicians and insurance companies manage the care and cost of cancer treatment and survivorship.
Dr. Robinson is an Associate Professor of Radiation Oncology at Washington University in St. Louis and Chief of Service for Stereotactic Body Radiation Therapy at the Siteman Cancer Center. His areas of clinical interest include lung and esophageal cancers, brain and spinal tumors, and stereotactic radiotherapy.
“Cliff brings demonstrated physician leadership, clinical expertise and research experience to our team,” said Andrew Cowen, Chief Executive Officer of Radialogica. “His commitment to quality and evidence-based practice will help inform our efforts to facilitate value-based care for cancer patients and reduce the growing burden of cancer survivorship.”
“I am very excited to formalize my longstanding collaboration with Radialogica,” said Dr. Robinson. “With an expanding portfolio of services and multiple projects with academia and payers assessing innovative methods for demonstrating quality and value of cancer care, the coming year promises to be quite productive. I look forward to providing necessary clinical guidance, and facilitating publication our results for public consumption and transparency.”
Radialogica, a privately held company based in St. Louis, is a healthcare analytics company focused on radiation oncology. It empowers healthcare providers and payers with tools, evidence and insight to enhance the quality and value of cancer treatment and reduce the physical and financial burden of cancer survivorship.
PR 2015_04
Version 1.0
8 December 2015
12.01.2015
Radialogica, a healthcare analytics company focused on radiation therapy for cancer patients, announced an agreement with Washington University School of Medicine in St. Louis to develop and manage a multi-institutional registry of medical data for cancer patients treated with proton therapy. The registry will be utilized by a consortium of proton therapy centers organized by Washington University that will contribute clinical information and outcomes data to establish the efficacy, cost-effectiveness and value of proton treatment.
Clinicians at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine initiated proton therapy service in December 2013 and have treated more than 250 adult and pediatric patients with a wide variety of complex tumors.
The proton therapy registry will capture a range of de-identified clinical information for consented patients regarding their diagnosis, treatment and follow-up. The platform will further support the acquisition of patient treatment plans and related medical imaging and dosimetry data, providing insight into practice patterns and response assessment.
“We are excited to launch the proton therapy registry and enable members of the proton community to work collaboratively to capture treatment and outcomes data,” said Jeffrey Bradley MD, Director of the S. Lee Kling Proton Therapy Center. “Combining clinical information, patient treatment plans and dosimetry data, and follow-up data will help advance our understanding of dose response, inform the development of treatment guidelines, and provide a foundation for evidencing the effectiveness and value of proton therapy.”
“We are delighted to partner with Washington University, Siteman Cancer Center and other members of the proton therapy community for the benefit of cancer patients,” said Andrew Cowen, Chief Executive Officer of Radialogica. “Proton therapy offers the promise of more targeted radiation delivery with fewer treatment-related side effects, and the potential for delivering superior patient outcomes while reducing the lifetime care and cost of cancer survivorship. We’re excited to leverage Radialogica’s technology and analytics platform to support this important work.”
About Radialogica
Radialogica, a privately held company based in St. Louis, is a healthcare analytics company focused on radiation oncology. It empowers healthcare providers and payers with tools, evidence and insight to enhance the quality and value of cancer treatment and reduce the physical and financial burden of cancer survivorship.
PR 2015_02
Version 1.0
1 December 2015
11.18.2015
The Department of Veterans Affairs (VA) today announced a new Radiation Oncology Practice Assessment (ROPA) program to leverage recent advances in information technology to improve radiation therapy cancer care for our nation’s Veterans.
VA is working with the American Society for Radiation Oncology (ASTRO), Washington University and Radialogica to provide radiation oncologists for the first time with continuous feedback on the progress of cancer therapy.
“We are pleased to be working with this country’s leading-class organizations on this innovative program, the first of its kind nationwide. Our Veterans deserve nothing less,” said Dr. Maureen McCarthy, VA acting assistant deputy undersecretary for health and patient care services.
Radiation is one of the three major treatments for cancer along with surgery and chemotherapy, with about 60% of cancer patients receiving radiation therapy. In recent years, there have been substantial clinical and technical advances in radiation oncology, resulting in new regimens with increased survival and improved quality of life.
Under ROPA, data will be abstracted from the VA’s highly sophisticated electronic medical record (EMR) system and the treatment management systems used to control radiation therapy delivery. Feedback reports will be provided to VA radiation oncologists with a detailed analysis of each patient treatment compared against national standards. Combined with the traditional cancer outcome measures of recurrence and patient survival, this assessment will provide the oncologist with a complete picture of the accuracy of each patient’s therapy and the patient’s response to therapy.
Washington University is excited to take the lead role in managing the program. “We have significant experience working with the National Cancer Institute to provide the platform we will use for these assessments. We are excited to bring that experience to bear on this landmark project on behalf of our nation’s Veterans,” said Jeff Michalski, MD, Washington University’s vice-chair of radiation oncology. “We are also pleased to engage a local radiation oncology informatics company, Radialogica LLC, who will provide a platform and services for data security, extraction and management.”
In the first year of the project, ASTRO’s disease-site specific experts will review measures for prostate and lung cancers, identifying metrics from the EMR to assess each one. “ASTRO is deeply committed to improving the quality of cancer care for our Veterans and all Americans. Our cancer experts are enthusiastic about this new opportunity to better measure and enhance radiation delivery with the goal of producing high quality patient outcomes,” said Bruce D. Minsky, MD, FASTRO, chair of ASTRO’s Board of Directors.
Once ROPA is fully implemented, VA radiation oncologists will receive continuously updated electronic peer reviews of each patient’s cancer evaluation, treatment and treatment outcome. Currently, VA hospitals, similar to community hospitals, use traditional, sporadic peer-reviews in a process referred to as On-going Professional Peer Evaluation (OPPE). ROPA peer reviews go well beyond the traditional OPPE and practice accreditation to create comprehensive, patient-centered reports in a web-based environment. VA radiation oncologists will see how changes in their clinical practice impact the success of each Veteran’s cancer treatment.
PR 2015_03
Version 1.0
18 November 2015
10.22.2015
Radialogica, a healthcare analytics company focused on radiation oncology for cancer patients, announced that its fullAccess™ software has been selected by PetCure Oncology, the leader in providing cancer care for pets, as the company’s platform for clinical collaboration and quality management. PetCure Oncology formally implemented fullAccess™ across its network of cancer centers earlier this month.
fullAccess™, successfully used to manage the quality and efficiency of radiation therapy in human cancer treatment, is a fully-integrated radiotherapy data display, communication and analysis platform that enables clinicians across the continuum of care to quickly and easily access, analyze, and share radiation therapy treatment plans and other medical records. Designed to simplify, streamline, and standardize the plan review process, fullAccess™ features a vendor-independent RT visualization environment that supports flexible review of diagnostic images and treatment plans from any location, robust analytics to evaluate and benchmark the quality and safety of radiation treatment plans, and clinical collaboration tools that facilitate access to clinical expertise and distribution of best practices.
“Partnering with Radialogica allows us to take the best practices from human oncology treatment planning and apply it to veterinary medicine,” said PetCure Oncology Chief Medical Officer Neal Mauldin. “Safety, exceptional quality and collaboration to optimize outcomes are extremely important to us, and Radialogica shares these important ideals. Their service has been outstanding and the fullAccess™ platform allows us to safely and effectively treat more pets through a truly collaborative and comprehensive approach.”
“To date, our focus has been on enhancing the quality of radiotherapy treatment and efficiency of clinical workflow within the human healthcare industry,” stated Andy Cowen, CEO of Radialogica. “We are thrilled to support the application of fullAccess™ within the veterinary field through PetCure Oncology and believe it is a testament to their team’s rigor and focus on quality of care.”
The progressive software complements PetCure Oncology’s mission to revolutionize cancer care for pets, which includes offering stereotactic radiosurgery (SRS), an advanced form of radiation therapy. Widely used in human cancer treatment, SRS offers tremendous benefits to pets by delivering high doses of radiation with sub-millimeter precision in a non-invasive, non-surgical manner. In addition to treating the patient with the intent to cure, SRS requires only 1-3 treatment sessions compared to 15-21 with conventional radiation therapy (CFRT), while minimizing both the risk and the side effects commonly associated with CFRT.
About Radialogica
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
About PetCure Oncology
Cancer accounts for nearly 50 percent of all disease-related pet deaths and is the leading cause of death in older dogs and cats. PetCure Oncology is revolutionizing cancer care for pets by establishing veterinary SRS centers across the country. Centers in Phoenix, Cincinnati, and Clifton, NJ, are operational. Locations in Wisconsin and Illinois are scheduled to open in the next few months, with many more in various stages of development across the country. To learn more or obtain a referral to PetCure Oncology, visit PetCureOncology.com or call (773) 850-3400.
PR 2015_01
Version 1.0
22 October 2015
11.01.2014
Radialogica announced that its Quality Management System has been certified to ISO 13485:2003 and the Canadian Medical Device Conformity Assessment System by SGS North America Inc. SGS also certified Radialogica’s fullAccess™ software product to European Medical Device Directive 93/42/EEC for CE Mark approval. These certifications position Radialogica to significantly strengthen its global market presence.
“We are delighted to announce this important milestone for our company and take pride in this recognition of our organizational capabilities,” said Andrew Cowen, Chief Executive Officer of Radialogica. “As a medical device manufacturer serving the needs of cancer patients and their healthcare providers, Radialogica maintains a demonstrated commitment to the highest levels of quality, consistent with international standards and regulatory requirements. We look forward to expanding our market presence and bringing the benefits of our unique product capabilities to cancer patients and oncology professionals in the European Union and beyond.”
fullAccess™ is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to quickly and easily access, analyze and share radiotherapy treatment plans and other medical records. Designed to simplify, streamline and standardize the plan review process for radiation oncologists, fullAccess™ features:
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on radiation therapy and the broader oncology market. The company’s mission is to empower healthcare providers and payers to improve the quality of oncology treatment and manage the growing physical and financial burden of cancer survivorship.
PR 2014_01
06.21.2013
Radialogica and Philips Healthcare announced that they have entered into a long-term licensing and distribution agreement to partner on the sale of Radialogica’s fullAccess software products by the Philips sales organization to the global radiation oncology market. fullAccess is a fully-integrated radiotherapy display, communication and analysis platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data.
“We are pleased to enter into this collaborative agreement with Philips to bring new and needed tools to the radiotherapy community, “ said Andrew Cowen, Chief Executive Officer of Radialogica. “Philips maintains a leading position in the field of radiation oncology, a large installed base of Pinnacle3 treatment planning systems, and strong distribution channels worldwide, and we look forward to partnering with them to accelerate the deployment of fullAccess for the benefit of our customers and their patients.”
“Pinnacle3 customers are demanding intuitive solutions for increasingly complex workflow,” said Dr. Susan Wallace, GM of Philips Radiation Oncology Systems. “The Radialogica offerings are a great example of implementing a meaningful solution based on detailed insight into the day-to-day challenges of the clinic. We’re thrilled to make fullAccess available to our customers as part of the Pinnacle3 portfolio.”
fullAccess supports flexible viewing of multi-modality DICOM-RT and other patient data from a standard PC or laptop, automated benchmarking and analysis of plan quality, and ready sharing of treatment plans between facilities and practitioners. These features are specifically designed to streamline communication and workflow within the clinic and enhance coordination and collaboration between providers for better patient care.
Radialogica, a privately held business based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, analyzed and shared by members of the treatment team and other vested stakeholders. For more information visit www.radialogica.com
Philips Healthcare is a recognized leader in radiation oncology with products in multi-modality imaging, simulation and treatment planning. It is acknowledged as a provider of industry leading, state-of-the-art solution to radiation therapy clinicians that excel in accuracy, breadth of application, automation, workflow and ease-of-use.
PR 2013_01
12.01.2012
Radialogica announced the successful installation of its fullAccess software platform at the University of Wisconsin-Madison. Clinicians at the UW-Carbone Cancer Center and the UW Human Oncology Department and Medical Physics Department will use fullAccess for plan review and electronic case conference.
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2012_01
09.18.2012
Radialogica announced it has entered into a Master Service Agreement with Washington University in St. Louis pursuant to which researchers and clinicians in the School of Medicine’s Department of Radiation Oncology at the Mallinckrodt Institute of Radiology and Siteman Cancer Center will collaborate with Radialogica on future product development activities.
The first project to be pursued under the agreement relates to clinical validation of Radialogica’s new fullReport software module, the latest offering within the fullAccess product platform. fullReport is a robust analytics tool designed to standardize and streamline radiotherapy plan evaluation and enhance treatment quality and data integrity. fullReport allows users to automatically extract user-defined DVH and other treatment plan metrics, generate custom reports, and benchmark plans against institutional criteria and historical performance in order to improve the quality and efficiency of plan review.
“We are delighted to partner with the clinicians at Washington University to develop and deploy next-generation software tools for radiation oncology,” said Andrew Cowen, Chief Executive Officer of Radialogica. “Washington University has demonstrated a continued commitment to clinical innovation and excellence, and we look forward to working together to help transform the standard of care within the field and make an impact on the lives of cancer patients.”
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2012_03
02.27.2012
Radialogica showcased the capabilities of its fullAccess software platform at the 2012 SRS/SBRT Scientific Meeting conducted by the Radiosurgery Society™ (RSS) in Carlsbad, California. Presenters at the RSS’s Performance and Quality Improvement Session (PQIS) used Radialogica’s fullAccess software to display their cases in an interactive visualization environment to enhance clinical discussion.
“The main objective of the PQIS session is to further improve patient treatments and care by providing practitioners an opportunity to present challenging case studies amid a panel of experts with active participation from clinical specialists from every field," said Kristine H. Gagliardi, Executive Director of the RSS. "An added feature at this year’s program was Radialogica’s fullAccess software providing a vastly improved ability to view and analyze multi-modality treatment plans rather than only simplified 2D images. Radialogica’s fullAccess software has elevated the sophistication of presentations during the PQIS session and we look forward to their presence and contribution at the SRS/SBRT Scientific Meeting 2013.”
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
The RSS is a multi-disciplinary non-profit organization, consisting of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of stereotactic radiosurgery and stereotactic body radiation therapy. Originally formed in 2002 as the CyberKnife® Society™, the RSS represents approximately 650 members who perform SRS and SBRT in hospitals and freestanding centers throughout the world. Nearly 500 participants from 17 countries attended the RSS’s 2012 annual meeting, its first as an independent society.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2012_02
12.30.2011
Radialogica announced the commercial release of DICOM query / retrieve functionality as a licensable feature of its fullAccess software platform. With query / retrieve capability, fullAccess users can access DICOM images stored on a centralized PACS and radiotherapy treatment plans that reside on a DICOM-RT PACS. Patient images and treatment plans can be viewed on any standard PC, providing a flexible review tool and remote access capability.
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2011_05
12.30.2011
Radialogica announced the commercial release of a new clinical trials data analysis tool for the Image-Guided Treatment QA Center (ITC) at Washington University in St. Louis. The tool is incorporated into Radialogica’s fullAccess software platform and will allow ITC clinical reviewers to automatically extract and analyze radiotherapy dose data collected for a clinical trial sponsored by Augmeniux, Inc.
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
The ITC serves as the administrative core of the NCI-sponsored Advanced-Technology QA Consortium (ATC) and provides software tools and data management services to support quality assurance for radiation oncology clinical trials. Augmenix is conducting a clinical trial of its SpaceOAR™ System, an implantable, absorbable product designed to protect vulnerable tissues during radiotherapy. Independent reviewers at the ITC will use the fullAccess™ data analysis tool to analyze treatment plans generated for patients participating in the trial to validate compliance with trial protocols.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2011_06
12.03.2011
Radialogica announced the successful installation of its fullAccess software platform at the ProCure Training and Development Center in Bloomington, Indiana. ProCure Treatment Centers, Inc., which operates the largest network of proton therapy centers across the U.S., will use Radialogica’s fullAccess software for centralized review and quality assurance of proton treatment plans and sharing of patient data with referring physicians, specialists and patients.
“The fullAccess software fills a void in radiotherapy workflow that plagued the process of sharing radiation therapy data among institutions in the past," said Niek Schreuder, Senior Vice President of Medical Physics and Technology at ProCure. "fullAccess can also be used to collate patient treatment information for intake rounds and for storage of very important treatment data in one single file. This is a feature that will serve the radiotherapy research community very well in the future.”
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2011_04
09.09.2011
Radialogica announced the successful installation of its fullAccess software platform at The Alvin J. Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine in St. Louis. Clinicians in the Department of Radiation Oncology will use Radialogica’s fullAccess software to facilitate distributed access to multi-vendor treatment plans and presentation of cases as part of weekly electronic chart rounds.
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2011_03
06.20.2011
Radialogica announced the successful installation of its fullAccess software platform at New York-Presbyterian / The University Hospital of Columbia and Cornell in New York. Clinicians in the Department of Radiation Oncology will use Radialogica’s fullAccess software to facilitate access to multi-vendor treatment plans and presentation of cases for peer review as part of weekly electronic chart rounds.
fullAccess is a fully-integrated radiotherapy data display, communication and analysis software platform that enables clinicians across the continuum of care to access, analyze and share radiotherapy treatment plans and other patient data. fullAccess supports flexible viewing of multi-modality diagnostic images and radiotherapy treatment plans from all major planning systems, and ready sharing of images and treatment plans with others inside and outside the clinic.
Radialogica, a privately held company based in St. Louis, is a healthcare IT company focused on advanced software solutions for radiation oncology and the broader healthcare market. The company’s mission is to improve the safety, quality and efficiency of care with innovative software tools that improve the way information is accessed, shared and analyzed by members of the treatment team and other vested stakeholders.
PR 2011_02
05.03.2011
Radialogica LLC, a medical software company focused on next-generation tools for radiation oncology, appointed Andrew Cowen to serve as its Chief Executive Officer. Mr. Cowen joins the executive leadership team comprised of company co-founders R. Scott Brame, Ph.D., President and Chief Operating Officer, and Sasa Mutic, Ph.D., Vice President and Chief Technology Officer.
“Andy brings a strong strategic orientation and entrepreneurial drive, proven leadership and management skills, and a demonstrated track record of success as President and CEO of CMS,” said Dr. Brame. “His background and experience in the radiotherapy field, along with his market knowledge and industry relationships, will be extremely valuable to Radialogica as we expand our product line and grow our business.”
“I am delighted to join the Radialogica team and look forward to working with Scott and Sasa to build a world-class company,” said Mr. Cowen. “Radialogica brings together a unique combination of clinicians, researchers, software engineers and medical device professionals, all united by a shared commitment to more efficient and effective care. I am excited to work with this talented and passionate group of individuals to bring innovative products into clinical practice for the benefit of our customers and their patients.”
Mr. Cowen previously served as President and Chief Executive Officer of CMS, Inc., the radiotherapy treatment planning company, where he led the successful strategic repositioning and operational restructuring of the business and subsequent sale to Elekta AB. Prior to joining CMS Mr. Cowen served for twelve years as an executive of Brown Brothers Harriman in its private equity investment group, with primary responsibility for Brown Brothers' healthcare-oriented venture and growth capital investments. He also served on the board of Directors of ProTom International, Inc. and the ASTRO Corporate Advisory Council. Mr. Cowen is a Phi Beta Kappa and summa cum laude graduate of Bowdoin College, and earned his MBA from the Wharton School of the University of Pennsylvania.
PR 2011_01